Scientists test new 'Seek-and-Destroy' drug for tough thyroid cancers
Disease control
Recruiting now
This is an early-stage study to test the safety and find the right dose of a new radioactive drug called 177Lu-CTR-FAPI for people with advanced thyroid cancer. The drug is designed to find and deliver radiation directly to cancer cells. The study will enroll 12 patients to see h…
Phase: PHASE1 • Sponsor: SHAOYAN LIU • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC